John Gladden is a seasoned professional in the oncology and genomics fields, currently serving as a Senior Oncology Specialist at BillionToOne since April 2024. In this role, John is focused on launching molecular diagnostics in oncology and collaborating with academic and community oncology centers. Prior to this, John has had a successful tenure at Guardant Health as an Account Executive, where achievements included being named to the President's Club in 2022. John's sales experience extends through various roles at Exagen Inc., CardioDx, and Merck, demonstrating a strong track record in sales management, training, and business development. An educator at heart, John began a career in teaching biology and environmental science before transitioning into the healthcare sector. John's educational background includes a Master of Science and a Bachelor of Science in Biology from Jacksonville State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices